{"DataElement":{"publicId":"3235519","version":"1","preferredName":"Antibody Response Laboratory Procedure Performed Type","preferredDefinition":"A description of the antibody response type.","longName":"3235510v1.0:3235512v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"3235510","version":"1","preferredName":"Antibody Response Laboratory Procedure Performed","preferredDefinition":"(AN-tih-BOD-ee) A type of protein made by certain white blood cells in response to a foreign substance (antigen). Each antibody can bind to only a specific antigen. The purpose of this binding is to help destroy the antigen. Antibodies can work in several ways, depending on the nature of the antigen. Some antibodies destroy antigens directly. Others make it easier for white blood cells to destroy the antigen._Response; a bodily process occurring due to the effect of some foregoing stimulus or agent._Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._Executed and carried through to completion.","longName":"3235508v1.0:2241241v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"3235508","version":"1","preferredName":"Antibody Response Laboratory Procedure","preferredDefinition":"(AN-tih-BOD-ee) A type of protein made by certain white blood cells in response to a foreign substance (antigen). Each antibody can bind to only a specific antigen. The purpose of this binding is to help destroy the antigen. Antibodies can work in several ways, depending on the nature of the antigen. Some antibodies destroy antigens directly. Others make it easier for white blood cells to destroy the antigen.:Response; a bodily process occurring due to the effect of some foregoing stimulus or agent.:Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","longName":"C16295:C25755:C25294","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Antibody","conceptCode":"C16295","definition":"A type of protein made by B lymphocytes in response to a foreign substance (antigen). Each antibody only binds to a specific antigen, helping to destroy the antigen directly or by assisting white blood cells to destroy the antigen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Response","conceptCode":"C25755","definition":"Any act or phenomena, or behavior, constituting a reply or reaction of a living organism or its part to some foregoing stimulus or agent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A32B237B-1967-0954-E040-BB89AD430712","latestVersionIndicator":"Yes","beginDate":"2011-05-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-05-13","modifiedBy":"ONEDATA","dateModified":"2011-05-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2241241","version":"1","preferredName":"Performed","preferredDefinition":"Performed; carried out.","longName":"C38000","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Performed","conceptCode":"C38000","definition":"Executed and carried through to completion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FA7953-8839-043D-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-07-08","modifiedBy":"ONEDATA","dateModified":"2005-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A32B237B-1975-0954-E040-BB89AD430712","latestVersionIndicator":"Yes","beginDate":"2011-05-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-05-13","modifiedBy":"KUMMEROA","dateModified":"2021-03-31","changeDescription":". 2021-3-31 ak OK to release per WZ.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3235512","version":"1","preferredName":"Antibody Response Type","preferredDefinition":"(AN-tih-BOD-ee) A type of protein made by certain white blood cells in response to a foreign substance (antigen). Each antibody can bind to only a specific antigen. The purpose of this binding is to help destroy the antigen. Antibodies can work in several ways, depending on the nature of the antigen. Some antibodies destroy antigens directly. Others make it easier for white blood cells to destroy the antigen._Response; a bodily process occurring due to the effect of some foregoing stimulus or agent._Type; a subdivision of a particular kind of thing.","longName":"3235512v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Protein conjugated HIB or pneumococcal vaccine","valueDescription":"Haemophilus Influenzae B Vaccine Or Pneumococcal Polyvalent Vaccine","ValueMeaning":{"publicId":"3235517","version":"1","preferredName":"Haemophilus Influenzae B Vaccine Or Pneumococcal Polyvalent Vaccine","longName":"3235517","preferredDefinition":"A vaccine against serotype b of the Gram-negative bacterium H. influenzae (Hib).  Hib vaccines contain polysaccharide-protein conjugate antigens that produce greater host immune responses than first-generation purified polysaccharide vaccine.  These vaccines may differ with regard to use of protein carriers, polysaccharides, diluents, and preservatives. (NCI04): Or; used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: An polyvalent vaccine used to prevent infection by the bacterium Streptococcus pneumoniae. Pneumococcal polyvalent vaccine contains highly purified capsular antigens from the 23 most prevalent or invasive pneumococcal types of Streptococcus pneumoniae to ensure cross-protection. Following vaccination, protective capsular type-specific antibody levels typically develop by the third week; serotype-specific antibody levels generally decline after 5-10 years.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Haemophilus Influenzae B Vaccine","conceptCode":"C1126","definition":"A vaccine against serotype b of the Gram-negative bacterium H. influenzae (Hib). Hib vaccines contain polysaccharide-protein conjugate antigens that produce greater host immune responses than first-generation purified polysaccharide vaccine. These vaccines may differ with regard to use of protein carriers, polysaccharides, diluents, and preservatives.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Pneumococcal Polyvalent Vaccine","conceptCode":"C1643","definition":"An polyvalent vaccine used to prevent infection by the bacterium Streptococcus pneumoniae. Pneumococcal polyvalent vaccine contains highly purified capsular antigens from the 23 most prevalent or invasive pneumococcal types of Streptococcus pneumoniae to ensure cross-protection. Following vaccination, protective capsular type-specific antibody levels typically develop by the third week; serotype-specific antibody levels generally decline after 5-10 years.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A32B237B-19E8-0954-E040-BB89AD430712","latestVersionIndicator":"Yes","beginDate":"2011-05-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-05-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A32B237B-1A01-0954-E040-BB89AD430712","beginDate":"2011-05-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-05-13","modifiedBy":"ONEDATA","dateModified":"2011-05-13","deletedIndicator":"No"},{"value":"Tetanus","valueDescription":"Tetanus","ValueMeaning":{"publicId":"3211476","version":"1","preferredName":"Tetanus","longName":"3211476","preferredDefinition":"A serious infectious disorder that follows wound contamination by the Gram-positive bacterium Clostridium tetani. The bacteria produce a neurotoxin called tetanospasmin, which causes muscle spasm in the jaw and other anatomic sites.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tetanus","conceptCode":"C85185","definition":"A serious infectious disorder that follows wound contamination by the Gram-positive bacterium Clostridium tetani. The bacteria produce a neurotoxin called tetanospasmin, which causes muscle spasm in the jaw and other anatomic sites.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E162-0395-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A32B237B-1A0B-0954-E040-BB89AD430712","beginDate":"2011-05-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-05-13","modifiedBy":"ONEDATA","dateModified":"2011-05-13","deletedIndicator":"No"},{"value":"Diptheria","valueDescription":"Diphtheria","ValueMeaning":{"publicId":"3235518","version":"1","preferredName":"Diphtheria","longName":"3235518","preferredDefinition":"A Gram-positive bacterial infection caused by Corynebacterium diphtheria.  It usually involves the oral cavity, pharynx, and nasal cavity.  Patients develop pseudomembranes in the affected areas and manifest signs and symptoms of an upper respiratory infection.  The diphtheria toxin may cause myocarditis, polyneuritis, and other systemic effects.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diphtheria","conceptCode":"C34541","definition":"A Gram-positive bacterial infection caused by Corynebacterium diphtheriae. It usually involves the oral cavity, pharynx, and nasal cavity. Patients develop pseudomembranes in the affected areas and manifest signs and symptoms of an upper respiratory infection. The diphtheria toxin may cause myocarditis, polyneuritis, and other systemic effects.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A32B237B-1A17-0954-E040-BB89AD430712","latestVersionIndicator":"Yes","beginDate":"2011-05-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-05-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A32B237B-1A30-0954-E040-BB89AD430712","beginDate":"2011-05-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-05-13","modifiedBy":"ONEDATA","dateModified":"2011-05-13","deletedIndicator":"No"},{"value":"Isohemagglutinin anti-B","valueDescription":"Isohemagglutinin Anti-B","ValueMeaning":{"publicId":"3252722","version":"1","preferredName":"Isohemagglutinin Anti-B","longName":"3252722","preferredDefinition":"An antibody that is reactive towards the B antigen present on the surface of some red blood cells. They are usually IgM antibodies and are isoantibodies, antibodies produced by an individual against antigens produced by members of the same species (isoantigens).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Isohemagglutinin Anti-B","conceptCode":"C97348","definition":"An antibody that is reactive towards the B antigen present on the surface of some red blood cells. They are usually IgM antibodies and are isoantibodies, antibodies produced by an individual against antigens produced by members of the same species (isoantigens).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7E1ED79-B7A1-3062-E040-BB89AD431105","latestVersionIndicator":"Yes","beginDate":"2011-07-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-07-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A7E1ED79-B7BA-3062-E040-BB89AD431105","beginDate":"2011-07-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-07-12","modifiedBy":"ONEDATA","dateModified":"2011-07-12","deletedIndicator":"No"},{"value":"Isohemagglutinin anti-A","valueDescription":"Isohemagglutinin Anti-A","ValueMeaning":{"publicId":"3252723","version":"1","preferredName":"Isohemagglutinin Anti-A","longName":"3252723","preferredDefinition":"An antibody that is reactive towards the A antigen present on the surface of some red blood cells. They are usually IgM antibodies and are isoantibodies, antibodies produced by an individual against antigens produced by members of the same species (isoantigens).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Isohemagglutinin Anti-A","conceptCode":"C97347","definition":"An antibody that is reactive towards the A antigen present on the surface of some red blood cells. They are usually IgM antibodies and are isoantibodies, antibodies produced by an individual against antigens produced by members of the same species (isoantigens).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7E1ED79-B7C6-3062-E040-BB89AD431105","latestVersionIndicator":"Yes","beginDate":"2011-07-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-07-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A7E1ED79-B7DF-3062-E040-BB89AD431105","beginDate":"2011-07-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-07-12","modifiedBy":"ONEDATA","dateModified":"2011-07-12","deletedIndicator":"No"},{"value":"Bacteriophage phi X-174 or other neoantigen","valueDescription":"Bacteriophage Phi X 174 Or Other Tumor Antigen","ValueMeaning":{"publicId":"3252724","version":"1","preferredName":"Bacteriophage Phi X 174 Or Other Tumor Antigen","longName":"3252724","preferredDefinition":"A bacteriophage that infects E. coli. Its genome is a circular DNA of 5386 bases.: Or; used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Different than the one(s) previously specified or mentioned.: 1. antigens that may be frequently associated with tumors or may be specifically found on tumor cells of the same origin (tumor specific); 2. tumor antigens may also be associated with replication and transformation by certain DNA tumor viruses, including adenoviruses and papovaviruses. Neoantigens. Any immunologically detectable marker whose presence or amount indicates the presence of a tumor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bacteriophage Phi X 174","conceptCode":"C97346","definition":"A bacteriophage that infects E. coli. Its genome is a circular DNA of 5386 bases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Tumor Antigen","conceptCode":"C912","definition":"1. antigens that may be frequently associated with tumors or may be specifically found on tumor cells of the same origin (tumor specific); 2. tumor antigens may also be associated with replication and transformation by certain DNA tumor viruses, including adenoviruses and papovaviruses. Neoantigens. Any immunologically detectable marker whose presence or amount indicates the presence of a tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A7E1ED79-B7EE-3062-E040-BB89AD431105","latestVersionIndicator":"Yes","beginDate":"2011-07-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-07-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A7E1ED79-B807-3062-E040-BB89AD431105","beginDate":"2011-05-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-07-12","modifiedBy":"ONEDATA","dateModified":"2011-07-12","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3235511","version":"1","preferredName":"Antibody Response Type","preferredDefinition":"(AN-tih-BOD-ee) A type of protein made by certain white blood cells in response to a foreign substance (antigen). Each antibody can bind to only a specific antigen. The purpose of this binding is to help destroy the antigen. Antibodies can work in several ways, depending on the nature of the antigen. Some antibodies destroy antigens directly. Others make it easier for white blood cells to destroy the antigen.:Response; a bodily process occurring due to the effect of some foregoing stimulus or agent.:Type; a subdivision of a particular kind of thing.","longName":"C16295:C25755:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Antibody","conceptCode":"C16295","definition":"A type of protein made by B lymphocytes in response to a foreign substance (antigen). Each antibody only binds to a specific antigen, helping to destroy the antigen directly or by assisting white blood cells to destroy the antigen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Response","conceptCode":"C25755","definition":"Any act or phenomena, or behavior, constituting a reply or reaction of a living organism or its part to some foregoing stimulus or agent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A32B237B-1992-0954-E040-BB89AD430712","latestVersionIndicator":"Yes","beginDate":"2011-05-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-05-13","modifiedBy":"ONEDATA","dateModified":"2011-05-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A32B237B-19A3-0954-E040-BB89AD430712","latestVersionIndicator":"Yes","beginDate":"2011-05-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-05-13","modifiedBy":"KUMMEROA","dateModified":"2021-03-31","changeDescription":".-2021-3-31 ak OK to release per WZ.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"3234637","version":"1","longName":"2131r2: Immune Deficiencies Post-HSCT Data","context":"NHLBI"},{"publicId":"3638517","version":"1","longName":"2031r2: Immune Deficiencies Pre-HSCT Data","context":"NHLBI"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"What were the response types","type":"Preferred Question Text","description":"What were the response types to the antibody assessed?","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A32B237B-1A41-0954-E040-BB89AD430712","latestVersionIndicator":"Yes","beginDate":"2011-05-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-05-13","modifiedBy":"KUMMEROA","dateModified":"2021-03-31","changeDescription":". 2021-3-31 ak OK to release per WZ. 2021-3-4 ak System generated def displayed as alt def.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}